Interview
![]()
Tenax Therapeutics Working on Phase 2 Trial
Anthony DiTonno, CEO of Tenax Therapeutics, talks about what’s on the horizon for financing and the...
January 22nd, 2019
Interview
![]()
Propanc’s Cancer Stem Cell Technology Ready for the Clinic
James Nathanielsz, CEO of Propanc Biopharma, talks about preclinical development, funding, cancer stem cells and more.
January 22nd, 2019
5 Top Weekly NASDAQ Biotech Stocks: Index Up During...
Axsome Therapeutics, Checkpoint Therapeutics, Bellerophon Therapeutics, Enochian Bioscience and Equillium were last week's top gainers.
January 13th, 2019
Notes from the Floor: Biotech Showcase, Day 2
The Biotech Showcase takes place in San Francisco from January 7 to 9. Here’s what happened...
January 8th, 2019
Verrica Releases Positive Phase 3 Results
Both trials achieved statistical significance for the primary objective with Verrica’s VP-102, a candidate for molluscum...
January 3rd, 2019
Big Pharma Collaboration Announced with Cocystal and Merck
Cocrystal Pharma and Merck have announced a new partnership that ignited investor attention in early trading...
January 3rd, 2019
Adamis Submits NDA for New Product
The application was for Adamis’ naloxone pre-filled single dose syringe (PFS) product candidate, as a treatment...
January 2nd, 2019